XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.3
Note 8 - Financial Instruments With Off-balance-sheet Risk (Tables)
9 Months Ended
Sep. 30, 2023
Notes Tables  
Schedule of Fair Value, off-Balance-Sheet Risks [Table Text Block]
  

September 30, 2023

  

December 31, 2022

 
      

Fair Value of

      

Fair Value of

 
      

Unfunded

      

Unfunded

 
  

Principal

  

Commitment

  

Principal

  

Commitment

 
  

Balance

  

Liability

  

Balance

  

Liability

 
  

(In thousands)

  

(In thousands)

 

BrightInsight, Inc.

 $18,250  $241  $21,000  $278 

Britecore Holdings, Inc.

  5,000   72   5,000   66 

Candesant Biomedical Corporation

  10,000   151       

Castle Creek Biosciences

  4,000   72   4,000   72 

Divergent Technologies, Inc.

  11,250   118   22,500   236 

Elligo Healthcare Research, Inc.

  15,000   194       

Engage3, LLC

        8,000   40 

Groundspeed Analytics, Inc.

        15,000   150 

Hound Labs, Inc.

        7,500   88 

KSQ Therapeutics, Inc.

        10,000   100 

Lytics, Inc.

  4,000   52   5,000   65 

Mirantis, Inc.

  15,000   136       

Native Microbials, Inc.

        7,500   72 

Noodle Partners, Inc.

  5,000   61       

Optoro, Inc.

  6,250      15,000   38 

PDS Biotechnology Corporation

        10,000   158 

Robin Healthcare, Inc.

        10,000   100 

SafelyYou, Inc.

  20,000   270       

Scientia Vascular, Inc.

  5,000   55   10,000   110 

Slingshot Aerospace, Inc.

        5,000   64 

Sonex Health, Inc.

  15,000   176       

Supply Network Visibility Holdings, LLC

  10,000   35       

Swift Health Systems Inc.

  11,500      25,500   105 

Tallac Therapeutics, Inc.

  10,000   229       

Temperpack Technologies, Inc.

  6,500   14   9,000   19 

Viken Detection Corporation

  10,000   160       

Total

 $181,750  $2,036  $190,000  $1,761